Careful consideration when responding to new data: dolutegravir and pregnancy
This case highlights the current complexities of managing women in the early stages of pregnancy presenting on dolutegravir-based regimens. When responding to new data, there is an important decision to be made, between the potential, uncertain risk of teratogenicity against the potential increased...
Main Authors: | C. Foster, S. Fidler, E.G.H. Lyall, G.P.T. Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | Journal of Virus Eradication |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020302624 |
Similar Items
-
Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir
by: Supphachoke Khemla, et al.
Published: (2023-04-01) -
Case study: New onset of neuropsychiatric symptoms following switching to a dolutegravir regimen
by: Ahmed Badat, et al.
Published: (2022-03-01) -
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
by: Amedeo F. Capetti, et al.
Published: (2017-09-01) -
Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting
by: Jose L. Casado, et al.
Published: (2019-04-01) -
Treatment Satisfaction and Its Associated Factors of Dolutegravir Based Regimen in a Resource Limited Setting
by: Mehari EA, et al.
Published: (2021-06-01)